Compliance to accelerometry before treatment for inoperable lung cancer

Autor: Leon Straker, Siobhan Dormer, Chelsea Milner, Samantha Bowyer, Vinicius Cavalheri, Joanne A. McVeigh, Carolyn J. Peddle-McIntyre, Kirsten Mooney, Daniel A. Galvão, Jeanie Leong, Rajesh Thomas, David Manners
Rok vydání: 2020
Předmět:
Zdroj: Physiotherapists.
DOI: 10.1183/13993003.congress-2020.263
Popis: Introduction: Data on device-measured physical activity (PA) and sedentary behaviour (SB) in the period before treatment commencement in people with inoperable lung cancer could help guide PA goals during and after treatment. However, the feasibility of collecting these data during such a stressful (and often short) period has not been reported. Aim: In people with inoperable lung cancer, to (i) examine compliance to accelerometry in the period before treatment; and (ii) describe their time spent in PA and SB. Method: People diagnosed with inoperable lung cancer, with Eastern Cooperative Oncology Group (ECOG) performance status 0-2, without brain metastases, wore an accelerometer (Actigraph GT9X) on their waist for 7 days before treatment. Compliance was measured as the percent of people who had ≥4 valid days (i.e. 10 h/day of wear-time). Results: Sixty-eight participants consented (44 males; 71±11yr), 62 were provided with the accelerometer, and 60 of them (97%) returned the device. No complications were reported on accelerometer use. Fifty-seven (95%) had ≥4 valid days of wear-time. Participants mean step count was 7,633±3,569 steps/day and they spent 600±116 min/day in SB. Compared to those with better performance status (ECOG 0/1; n=47), participants with poorer performance status (ECOG 2; n=10) had a lower step count (mean difference [95% CI] 2,480 [112; 4847] steps/day) and spent more time in SB (61 [7; 115] min/day). Conclusion: Compliance to accelerometry before lung cancer treatment was high. Participants with poorer performance status were less active and 1 h/day more sedentary than those with better performance status. Such data could guide PA and SB goal setting during and after treatment.
Databáze: OpenAIRE